Gujarat Narmada Valley Fertilizers & Chemicals Limited has appointed Dr. Mamata Biswal as an additional independent director, effective August 20, 2026. The Board of Directors approved the appointment based on the recommendation of the Nomination and Remuneration Committee.

Dr. Biswal will serve a first term of three consecutive years, running from August 20, 2026, to August 19, 2029. Her appointment is not liable to retire by rotation and remains subject to the approval of the company's members at the ensuing annual general meeting.

Director Profile

Dr. Mamata Biswal is a Professor of Law and ICSSR Senior Research Fellow at Gujarat National Law University. She holds a Ph.D. in Law and an LL.M. in Commercial Law, with over 25 years of teaching and research experience.

Key aspects of her professional background include:

• Serving as a Visiting Scholar at the University of Illinois, Urbana-Champaign, USA.
• Acting as a resource person for training programs for Grade A officers of IFSCA, CBI Law Officers, and Probationary Officers of the Indian Corporate Law Service.
• Coordinating certificate courses on Corporate Governance, Company Law 2013, Insolvency and Bankruptcy Laws, and Financial Market Laws.

Regulatory Compliance

The appointment was disclosed pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dr. Biswal has confirmed that she meets the criteria for independence under Section 149 of the Companies Act, 2013, and Regulation 16 of the Listing Regulations. She also confirmed that she has not been debarred from holding office as a director by any SEBI order or other authority.

The company stated there are no relationships between directors regarding this appointment.

Gujarat Narmada Valley Fertilizers & Chemicals Limited reported a standalone net profit after tax (PAT) of ₹310 crore for the first quarter of FY27, marking a 297% year-on-year increase from the ₹78 crore recorded in Q1FY26. The company’s operating revenue climbed to ₹2,238 crore in Q1FY27, up from ₹1,601 crore in the corresponding period of the previous fiscal year. This performance underscores the impact of improved realizations across its product basket, which offset lower volumes in most categories. Investors should note that year-on-year comparisons are skewed by an annual turnaround at the Bharuch complex during Q1FY26, which suppressed prior-period figures. The results were approved by the Board of Directors at its meeting held on August 05, 2026.

The filing was submitted pursuant to Regulation 33 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. GNFC announced that its senior management participated in an investor and analyst meet on August 06, 2026. The statutory auditors of the Company have carried out a 'limited review' of these results.

Financial Performance

Quarter-on-quarter, GNFC’s PAT decreased to ₹310 crore from ₹392 crore in Q4FY26. Profit before tax (PBT) also contracted to ₹416 crore from ₹526 crore in the preceding quarter. Management attributed this sequential decline to lower production volumes and elevated fixed costs. However, total revenue remained relatively stable at ₹2,339 crore compared to ₹2,333 crore in Q4FY26. The change in other comprehensive income was driven by fluctuations in the fair market value of quoted and unquoted investments, alongside actuarial adjustments to employee benefit obligations.

Segment Analysis

The chemicals segment emerged as the primary profit driver, contributing ₹425 crore to the segment result in Q1FY27, up significantly from ₹136 crore in Q1FY26. Revenue from chemicals rose to ₹1,569 crore from ₹1,005 crore year-on-year, fueled by higher realizations. Conversely, the fertilizers segment recorded a loss of ₹85 crore, widening from a loss of ₹100 crore in Q1FY26 but deteriorating sequentially from a loss of ₹24 crore in Q4FY26. This decline was due to higher input costs, the absence of one-time income received in the previous quarter, and increased fixed costs, partially mitigated by better realizations.

Operational Updates and Projects

During the earnings call, Executive Director and CFO D.V. Parikh highlighted that profits for Q1 were the second highest in the company's history after Q1FY22. He noted that while war-related escalations caused viability issues for plants like acetic acid, ethyl acetate, and TDI during the quarter, most have resumed operations by early August. The overdue Dahej project has started producing steam, offering substantial cost relief to the TDI-II plant by replacing costly gas with coal. Parikh estimated savings of ₹30,000 to ₹40,000 per metric ton of TDI due to this switch.

Capital Expenditure and Cash Position

GNFC incurred capital expenditure of ₹300 crore in capital work in progress (CWIP) during Q1FY27. The company targets an additional ₹1,200 crore to ₹1,500 crore for the full year, bringing total capex to ₹1,500 crore–₹1,800 crore. D.V. Parikh stated that cash on hand stands at approximately ₹4,000 crore, invested across G-Sec, GSFS, and bank instruments. The total projects on hand amount to ₹2,800 crore, with another ₹1,500 crore planned over the next two years.

What the Numbers Show

A critical observation is the divergence between top-line growth and margin pressure in the fertilizers division. While chemical revenues surged, the fertilizers segment continued to operate at a loss, highlighting structural cost challenges in urea production. Geopolitical tensions have adversely affected feedstock spreads, creating value addition gaps where feed costs have risen faster than final output realizations. Despite these headwinds, the company maintains consistent profitability overall, leveraging its multi-product basket to stabilize financial outcomes.